BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 17096647)

  • 1. Effects of hydroxyurea on malaria, parasite growth and adhesion in experimental models.
    Pino P; Taoufiq Z; Brun M; Tefit M; Franetich JF; Ciceron L; Krishnamoorthy R; Mazier D
    Parasite Immunol; 2006 Dec; 28(12):675-80. PubMed ID: 17096647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyurea downregulates endothelin-1 gene expression and upregulates ICAM-1 gene expression in cultured human endothelial cells.
    Brun M; Bourdoulous S; Couraud PO; Elion J; Krishnamoorthy R; Lapoumeroulie C
    Pharmacogenomics J; 2003; 3(4):215-26. PubMed ID: 12931135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence of Plasmodium falciparum infected erythrocytes to CHO-745 cells and inhibition of binding by protein A in the presence of human serum.
    Andrews KT; Adams Y; Viebig NK; Lanzer M; Schwartz-Albiez R
    Int J Parasitol; 2005 Sep; 35(10):1127-34. PubMed ID: 16051246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytoadherence of Plasmodium falciparum and complications of malaria].
    Trossaert M; Dieye A; Dieye Y; Sarthou JL
    Dakar Med; 1991; 36(2):192-7. PubMed ID: 1842780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
    Covas DT; de Lucena Angulo I; Vianna Bonini Palma P; Zago MA
    Haematologica; 2004 Mar; 89(3):273-80. PubMed ID: 15020264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis: a potential triggering mechanism of neurological manifestation in Plasmodium falciparum malaria.
    Touré FS; Ouwe-Missi-Oukem-Boyer O; Bisvigou U; Moussa O; Rogier C; Pino P; Mazier D; Bisser S
    Parasite Immunol; 2008 Jan; 30(1):47-51. PubMed ID: 18086016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Febrile temperatures induce cytoadherence of ring-stage Plasmodium falciparum-infected erythrocytes.
    Udomsangpetch R; Pipitaporn B; Silamut K; Pinches R; Kyes S; Looareesuwan S; Newbold C; White NJ
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11825-9. PubMed ID: 12177447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of current and emerging strategies for reducing morbidity from malaria in sickle cell disease.
    Aneni EC; Hamer DH; Gill CJ
    Trop Med Int Health; 2013 Mar; 18(3):313-27. PubMed ID: 23320577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo sequestration of Plasmodium falciparum-infected human erythrocytes: a severe combined immunodeficiency mouse model for cerebral malaria.
    Willimann K; Matile H; Weiss NA; Imhof BA
    J Exp Med; 1995 Sep; 182(3):643-53. PubMed ID: 7650476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding Heterogeneity of Plasmodium falciparum to Engineered 3D Brain Microvessels Is Mediated by EPCR and ICAM-1.
    Bernabeu M; Gunnarsson C; Vishnyakova M; Howard CC; Nagao RJ; Avril M; Taylor TE; Seydel KB; Zheng Y; Smith JD
    mBio; 2019 May; 10(3):. PubMed ID: 31138740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral malaria: role of microparticles and platelets in alterations of the blood-brain barrier.
    Combes V; Coltel N; Faille D; Wassmer SC; Grau GE
    Int J Parasitol; 2006 May; 36(5):541-6. PubMed ID: 16600245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Plasmodium falciparum-infected red blood cell.
    Tilley L; Dixon MW; Kirk K
    Int J Biochem Cell Biol; 2011 Jun; 43(6):839-42. PubMed ID: 21458590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-transcriptome analysis of Plasmodium falciparum field isolates: identification of new pathogenicity factors.
    Siau A; Toure FS; Ouwe-Missi-Oukem-Boyer O; Ciceron L; Mahmoudi N; Vaquero C; Froissard P; Bisvigou U; Bisser S; Coppee JY; Bischoff E; David PH; Mazier D
    J Infect Dis; 2007 Dec; 196(11):1603-12. PubMed ID: 18008243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea.
    Conran N; Fattori A; Saad ST; Costa FF
    Am J Hematol; 2004 Aug; 76(4):343-7. PubMed ID: 15282666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of endothelial activation: a new way to treat cerebral malaria?
    Wassmer SC; Cianciolo GJ; Combes V; Grau GE
    PLoS Med; 2005 Sep; 2(9):e245. PubMed ID: 16104828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the adhesion of sickle cells and malarial-parasitized red cells to cultured endothelium.
    Rowland PG; Nash GB; Cooke BM; Stuart J
    J Lab Clin Med; 1993 May; 121(5):706-13. PubMed ID: 8478598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Falciform anemia and Plasmodium falciparum malaria: a threat to flap survival?].
    Mariéthoz S; Pittet B; Loutan L; Humbert J; Montandon D
    Ann Chir Plast Esthet; 1999 Feb; 44(1):81-8. PubMed ID: 10188298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyurea and new agents for the treatment of sickle cell disease.
    Rodgers GP
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):713-5. PubMed ID: 16163257
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cerebral malaria, a key role for endothelial cells?].
    Pino P; Nitcheu J; Mazier D
    J Soc Biol; 2004; 198(3):187-92. PubMed ID: 15662934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy.
    Iyamu EW; Cecil R; Parkin L; Woods G; Ohene-Frempong K; Asakura T
    Br J Haematol; 2005 Nov; 131(3):389-94. PubMed ID: 16225659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.